Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in Early-stage Parkinson's Disease
NCT07804381Phase 2Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Dec 2026
- Primary completion
- Mar 2029
01
Overview
A Phase 2 trial of sitagliptin in Parkinson's disease (PD), sponsored by Yonsei University. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
sitagliptin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07804381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804381.